<?xml version="1.0" encoding="utf-8" ?>
<journal xmlns:xlink="http://www.w3.org/1999/xlink" editors-choice-status="yes">
    <journal-front>
        <journal-meta>
            <journal-id journal-id-type="publisher-id">139</journal-id>
            <journal-code>ccand</journal-code>
            <journal-eureka-code-one>CCAND</journal-eureka-code-one>
            <nid nid-status="current">110380</nid>
            <journal-title>Clinical Cancer Drugs</journal-title>
            <full-journal-title>Clinical Cancer Drugs</full-journal-title>
            <journal-seo-title>clinical-cancer-drugs</journal-seo-title>
            <journal-issn-list>
                <journal-issn issn-type="online">2212-6988</journal-issn>
                <journal-issn issn-type="print">2212-697X</journal-issn>
            </journal-issn-list>
            <journal-aims-scope>
                <p>
                    <bold>Clinical Cancer Drugs</bold> publishes original research, full-length reviews/ mini reviews, and thematic issues in all core areas of translational and clinical cancer drug research.</p>
                <p>The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading  for clinical oncologists, toxicologists, medicinal chemists, and pharmacologists.</p>
            </journal-aims-scope>
            <journal-current-volume>6</journal-current-volume>
            <journal-current-issues>2</journal-current-issues>
            <journal-current-year>2019</journal-current-year>
            <journal-cover-image>ccand-journal-cover.gif</journal-cover-image>
            <journal-insight>http://www.clinicalcancerdrugs.com/index.php</journal-insight>
<journal-history>Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.</journal-history>
            <journal-description>The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents.  Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses.  The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.</journal-description>
            <keyword-group>
                <keyword>Clinical Cancer Drugs</keyword>
                <keyword>translational and clinical cancer drug </keyword>
                <keyword>research methodologies, and analyses</keyword>
            </keyword-group>
            <social-media-link-list>
                <social-media-link social-media-link-type="facebook">https://www.facebook.com/pages/Bentham-Science-Clinical-TrialsMedicine-Journals/780819655292338?fref=ts</social-media-link>
                <social-media-link social-media-link-type="linkedin">http://www.linkedin.com/company/bentham-science-publishers---uae</social-media-link>
            </social-media-link-list>
            <journal-flyer>ccand-flyer.pdf</journal-flyer>
            <journal-email>
                <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ccand@benthamscience.net">ccand@benthamscience.net</email>
            </journal-email>
            <journal-management-system>
                <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://bsp-cms.eurekaselect.com/index.php/CCAND">bsp-cms.eurekaselect.com/index.php/CCAND</uri>
            </journal-management-system>
        </journal-meta>
    </journal-front>
    <journal-body>
        <agency-list>
            <agency order='first'>
                <agency-id>IDX1</agency-id>
                <agency-name>EMBASE</agency-name>
                <agency-logo>EMBASE.jpg</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX2</agency-id>
                <agency-name>Chemical Abstracts Service/SciFinder</agency-name>
                <agency-logo>cas.jpg</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX1</agency-id>
                <agency-name>Google Scholar</agency-name>
            </agency>
            <agency>
                <agency-id>IDX3</agency-id>
                <agency-name>PubsHub</agency-name>
                <agency-logo>pubshub.jpg</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX1</agency-id>
                <agency-name>J-Gate</agency-name>
                <agency-logo>jgate.png</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX5</agency-id>
                <agency-name>CNKI Scholar</agency-name>
                <agency-logo>CNKI.jpg</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX6</agency-id>
                <agency-name>Suweco CZ</agency-name>
                <agency-logo>suweco.jpg</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX6</agency-id>
                <agency-name>EBSCO</agency-name>
                <agency-logo>EBSCO.gif</agency-logo>
            </agency>
            <agency>
                <agency-id>IDX1</agency-id>
                <agency-name>Ulrich's Periodicals Directory</agency-name>
            </agency>
            <agency>
                <agency-id>IDX1</agency-id>
                <agency-name>JournalTOCs</agency-name>
            </agency>
        </agency-list>
    </journal-body>
</journal>